Loading
Gynaecologic oncologist and immunotherapy researcher who directs the University of Chicago Medicine Comprehensive Cancer Center.
Kunle Odunsi, MD, PhD, is Director of the University of Chicago Medicine Comprehensive Cancer Center, an NCI-designated comprehensive cancer centre. A gynaecologic oncologist, his research focuses on immunotherapy and vaccine therapy for cancer, particularly ovarian cancer, including NY-ESO-1 targeted vaccines and adoptive T-cell approaches. His role is listed on the centre's leadership page.
| Title | Journal | Year |
|---|---|---|
| CXCR6 by increasing retention of memory CD8 + T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer | Journal for ImmunoTherapy of Cancer | 2021 |
| Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses | Science Translational Medicine | 2022 |
| IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation | Frontiers in Immunology | 2021 |
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares University of Chicago Medicine Comprehensive Cancer Center and the tags clinician-scientist, immunotherapy.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares University of Chicago Medicine Comprehensive Cancer Center and the tag immunotherapy.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares the tags leadership, clinician-scientist, immunotherapy.